Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
113.04
106.51
47.71
122.06
85.24
41.14
90.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
113.04
106.51
47.71
122.06
85.24
41.14
90.55
Raw Material Cost
0.46
0.44
0.46
0.47
0.47
0.48
0.48
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.20
9.14
7.89
8.43
8.36
8.07
8.91
Selling and Distribution Expenses
11.31
12.03
19.29
21.91
16.80
24.26
33.33
Other Expenses
1.48
1.24
1.35
1.36
1.45
1.89
1.45
Total Expenditure (Excl Depreciation)
33.73
33.97
41.16
44.38
40.17
51.69
57.26
Operating Profit (PBDIT) excl Other Income
79.3
72.5
6.6000000000000005
77.69999999999999
45.099999999999994
-10.5
33.3
Other Income
1.63
1.74
1.54
0.97
0.86
0.91
0.78
Operating Profit (PBDIT)
81.39
74.72
8.55
79.13
46.39
-9.16
34.55
Interest
7.20
9.14
7.89
8.43
8.36
8.07
8.91
Exceptional Items
0.00
0.04
0.25
-2.20
0.25
-18.56
-0.07
Gross Profit (PBDT)
112.58
106.06
47.25
121.58
84.77
40.66
90.06
Depreciation
0.46
0.44
0.46
0.47
0.47
0.48
0.48
Profit Before Tax
73.73
65.17
0.46
68.02
37.82
-36.27
25.08
Tax
22.44
24.40
2.73
27.94
14.22
1.11
21.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.29
40.77
-2.28
40.08
23.60
-37.39
3.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.29
40.77
-2.28
40.08
23.60
-37.39
3.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.29
40.77
-2.28
40.08
23.60
-37.39
3.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-161.84
-217.14
-261.83
-264.16
-308.16
-334.05
-301.33
Earnings per share (EPS)
0.31
0.24
-0.01
0.23
0.14
-0.23
0.02
Diluted Earnings per share
0.31
0.24
-0.01
0.23
0.14
-0.23
0.02
Operating Profit Margin (Excl OI)
70.16%
68.1%
13.74%
63.64%
52.88%
-25.64%
36.77%
Gross Profit Margin
65.63%
61.61%
1.92%
56.12%
44.92%
-87.0%
28.23%
PAT Margin
45.37%
38.28%
-4.77%
32.84%
27.69%
-90.87%
3.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 6.10% vs 123.27% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 25.74% vs 1,873.91% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 9.32% vs 942.86% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -20.88% vs 15.19% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Ironwood Pharmaceuticals, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
113.04
219.06
-106.02
-48.40%
Other Operating Income
0.00
0.00
0.00
Total Operating income
113.04
219.06
-106.02
-48.40%
Raw Material Cost
0.46
59.40
-58.94
-99.23%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.20
2.31
4.89
211.69%
Selling and Distribution Expenses
11.31
136.04
-124.73
-91.69%
Other Expenses
1.48
2.67
-1.19
-44.57%
Total Expenditure (Excl Depreciation)
33.73
224.50
-190.77
-84.98%
Operating Profit (PBDIT) excl Other Income
79.31
-5.44
84.75
1,557.90%
Other Income
1.63
2.63
-1.00
-38.02%
Operating Profit (PBDIT)
81.39
22.92
58.47
255.10%
Interest
7.20
2.31
4.89
211.69%
Exceptional Items
0.00
-52.52
52.52
100.00%
Gross Profit (PBDT)
112.58
159.66
-47.08
-29.49%
Depreciation
0.46
25.73
-25.27
-98.21%
Profit Before Tax
73.73
-57.65
131.38
227.89%
Tax
22.44
0.72
21.72
3,016.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
51.29
-58.37
109.66
187.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.29
-58.37
109.66
187.87%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.29
-58.37
109.66
187.87%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-161.84
1,031.23
-1,193.07
-115.69%
Earnings per share (EPS)
0.31
-1.01
1.32
130.69%
Diluted Earnings per share
0.31
-1.01
1.32
130.69%
Operating Profit Margin (Excl OI)
70.16%
-2.49%
0.00
72.65%
Gross Profit Margin
65.63%
-14.57%
0.00
80.20%
PAT Margin
45.37%
-26.65%
0.00
72.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.30 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 6.10% vs 123.27% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 32.63% vs -9.75% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.13 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 25.74% vs 1,873.91% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 117.37% vs 2,722.22% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.98 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 9.32% vs 942.86% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 75.38% vs 65.45% in Jun 2025
Quarterly - Interest
Interest 0.72 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -20.88% vs 15.19% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -14.29% vs 12.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 70.16%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
